Showing 1 - 6 results of 6 for search 'Sara Gastoldi', query time: 0.03s Refine Results
  1. 1
    Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome

    Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome by Camillo Carrara, Camillo Carrara, Blerina Mataj, Sara Gastoldi, Piero Ruggenenti, Piero Ruggenenti, Savino Sciascia, Dario Roccatello

    Published 2024-09-01
    Get full text
    Article
  2. 2
    Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant

    Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Var... by Rossella Piras, Paraskevas Iatropoulos, Elena Bresin, Marta Todeschini, Sara Gastoldi, Elisabetta Valoti, Marta Alberti, Caterina Mele, Miriam Galbusera, Paola Cuccarolo, Ariela Benigni, Giuseppe Remuzzi, Marina Noris

    Published 2020-11-01
    Get full text
    Article
  3. 3
    An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome

    An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome by Sara Gastoldi, Sistiana Aiello, Miriam Galbusera, Matteo Breno, Marta Alberti, Elena Bresin, Caterina Mele, Rossella Piras, Lucia Liguori, Donata Santarsiero, Ariela Benigni, Giuseppe Remuzzi, Marina Noris

    Published 2023-02-01
    Get full text
    Article
  4. 4
    Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis

    Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis by Diego Curtò, Diego Curtò, Federica Tomatis, Sara Gastoldi, Miriam Galbusera, Marina Noris, Federico Raimondi, Federico Raimondi, Ferdinando Luca Lorini, Anna Falanga, Anna Falanga, Marina Marchetti, Giuseppe Remuzzi, Piero Ruggenenti, Piero Ruggenenti

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity

    Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity by Todor Tschongov, Swagata Konwar, Andreas Busch, Christian Sievert, Andrea Hartmann, Marina Noris, Sara Gastoldi, Sistiana Aiello, Andreas Schaaf, Jens Panse, Jens Panse, Peter F. Zipfel, Peter F. Zipfel, Paulina Dabrowska-Schlepp, Karsten Häffner

    Published 2024-05-01
    Get full text
    Article
  6. 6
    Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

    Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study. by Piero Ruggenenti, Fabiano Di Marco, Monica Cortinovis, Luca Lorini, Silvia Sala, Luca Novelli, Federico Raimondi, Sara Gastoldi, Miriam Galbusera, Roberta Donadelli, Caterina Mele, Rossella Piras, Marina Noris, Valentina Portalupi, Laura Cappelletti, Camillo Carrara, Federica Tomatis, Silvia Bernardi, Annalisa Perna, Tobia Peracchi, Olimpia Diadei, Ariela Benigni, Giuseppe Remuzzi

    Published 2021-01-01
    Get full text
    Article

Search Tools: